BioAge Labs Inc (NASDAQ: BIOA) kicked off on Tuesday, up 22.11% from the previous trading day, before settling in for the closing price of $12.62. Over the past 52 weeks, BIOA has traded in a range of $2.88-$14.46.
While this was happening, its average annual earnings per share was recorded 65.31%. With a float of $22.51 million, this company’s outstanding shares have now reached $35.85 million.
BioAge Labs Inc (BIOA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of BioAge Labs Inc is 37.23%, while institutional ownership is 35.53%. The most recent insider transaction that took place on Jan 02 ’26, was worth 95,490. In this transaction Chief Medical Officer of this company sold 7,433 shares at a rate of $12.85, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 02 ’26, when Company’s Officer proposed sale 7,433 for $13.41, making the entire transaction worth $99,677.
BioAge Labs Inc (BIOA) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -1.75 earnings per share (EPS), lower than consensus estimate (set at -0.66) by -1.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 65.31% per share during the next fiscal year.
BioAge Labs Inc (NASDAQ: BIOA) Trading Performance Indicators
Take a look at BioAge Labs Inc’s (BIOA) current performance indicators. Last quarter, stock had a quick ratio of 11.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 93.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.11, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -2.91 in one year’s time.
Technical Analysis of BioAge Labs Inc (BIOA)
Compared to the last year’s volume of 1.12 million, its volume of 0.79 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 44.55%.
During the past 100 days, BioAge Labs Inc’s (BIOA) raw stochastic average was set at 93.47%, which indicates a significant increase from 82.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.95 in the past 14 days, which was higher than the 0.47 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.23, while its 200-day Moving Average is $5.93. Nevertheless, the first resistance level for the watch stands at $16.96 in the near term. At $18.50, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.83. If the price goes on to break the first support level at $13.09, it is likely to go to the next support level at $10.76. Now, if the price goes above the second support level, the third support stands at $9.22.
BioAge Labs Inc (NASDAQ: BIOA) Key Stats
The company with the Market Capitalisation of 552.53 million has total of 35,855K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -71,110 K annual income. Company’s last quarter sales were recorded 2,050 K and last quarter income was -20,170 K.
